| scholarly article | Q13442814 |
| P50 | author | Daniel Konrad | Q58525924 |
| Stephan Wueest | Q82257484 | ||
| P2093 | author name string | D. Konrad | |
| S. Wueest | |||
| P2860 | cites work | The microbiota-gut-brain axis: neurobehavioral correlates, health and sociality | Q21129337 |
| High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse | Q21136177 | ||
| Obesity alters gut microbial ecology | Q24531503 | ||
| Diversity of the human intestinal microbial flora | Q24544241 | ||
| Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance | Q24617743 | ||
| Metagenomic analysis of the human distal gut microbiome | Q24633486 | ||
| Pathophysiology of human visceral obesity: an update | Q26864356 | ||
| An obesity-associated gut microbiome with increased capacity for energy harvest | Q27860515 | ||
| Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 | ||
| Microbial ecology: human gut microbes associated with obesity | Q27861004 | ||
| The gut microbiota as an environmental factor that regulates fat storage | Q28131676 | ||
| Honor thy symbionts | Q28202174 | ||
| Kupffer cell activation is a causal factor for hepatic insulin resistance | Q43252189 | ||
| Depot-specific differences in adipogenic progenitor abundance and proliferative response to high-fat diet | Q43297876 | ||
| Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes | Q43963463 | ||
| The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. | Q44318975 | ||
| Secretion of adipokines by human adipose tissue in vivo: partitioning between capillary and lymphatic transport | Q44591257 | ||
| The primary valves in the initial lymphatics during inflammation | Q45190692 | ||
| Adipose tissue inflammation contributes to short-term high-fat diet-induced hepatic insulin resistance. | Q46145371 | ||
| Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice | Q46663069 | ||
| Characterising metabolically healthy obesity in weight-discordant monozygotic twins | Q47206616 | ||
| Relationship between adipocyte size and adipokine expression and secretion | Q47310274 | ||
| Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria | Q47962035 | ||
| Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. | Q51497448 | ||
| Visceral Obesity in Men: Associations With Glucose Tolerance, Plasma Insulin, and Lipoprotein Levels | Q51605040 | ||
| Intestinal, adipose, and liver inflammation in diet-induced obese mice. | Q51673852 | ||
| The effect of fat removal on glucose tolerance is depot specific in male and female mice. | Q51744961 | ||
| Care for the community | Q56080202 | ||
| Studies of regional adipose transplantation reveal a unique and beneficial interaction between subcutaneous adipose tissue and the intra-abdominal compartment | Q57962488 | ||
| Short-term modifications in the distal gut microbiota of weaning mice induced by a high-fat diet | Q59154655 | ||
| Prox-1 and FOXC2 gene expression in adipose tissue: A potential contributory role of the lymphatic system to familial combined hyperlipidaemia | Q28240059 | ||
| Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation | Q28248826 | ||
| Intestinal barrier function: molecular regulation and disease pathogenesis | Q28250081 | ||
| Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity | Q28594528 | ||
| Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice | Q28730963 | ||
| Diet rapidly and reproducibly alters the human gut microbiome | Q29547454 | ||
| Metabolic endotoxemia initiates obesity and insulin resistance | Q29547720 | ||
| Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice | Q29615055 | ||
| CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein | Q29615189 | ||
| Microbiota and SCFA in lean and overweight healthy subjects | Q29615812 | ||
| Human gut microbiota in obesity and after gastric bypass | Q29615813 | ||
| CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity | Q29617380 | ||
| Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters | Q29617381 | ||
| Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome | Q29617424 | ||
| The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota | Q29619977 | ||
| Effect of ischemia on intestinal permeability of lipopolysaccharides | Q30651596 | ||
| Improved glucose tolerance in mice receiving intraperitoneal transplantation of normal fat tissue. | Q33276557 | ||
| Butter feeding enhances TNF-alpha production from macrophages and lymphocyte adherence in murine small intestinal microvessels | Q33301476 | ||
| The environment within: how gut microbiota may influence metabolism and body composition | Q33696549 | ||
| Microbes in gastrointestinal health and disease | Q33943525 | ||
| Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers | Q34024108 | ||
| Lymphatic lipid transport: sewer or subway? | Q34036806 | ||
| Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes | Q34036980 | ||
| Inverse regulation of basal lipolysis in perigonadal and mesenteric fat depots in mice. | Q34046431 | ||
| The endocannabinoid system links gut microbiota to adipogenesis | Q34078880 | ||
| Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation | Q34085293 | ||
| Abdominal superficial subcutaneous fat: a putative distinct protective fat subdepot in type 2 diabetes | Q34161629 | ||
| Role of the gut lymphatic system in multiple organ failure | Q34261847 | ||
| Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice | Q34322168 | ||
| Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? | Q34448790 | ||
| The Portal Theory Supported by Venous Drainage–Selective Fat Transplantation | Q34448796 | ||
| Interleukin-1β regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability | Q34558529 | ||
| Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings? | Q34563764 | ||
| Evidence for a role of developmental genes in the origin of obesity and body fat distribution | Q34597959 | ||
| Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity | Q34661023 | ||
| Human colonic microbiota associated with diet, obesity and weight loss | Q34823807 | ||
| Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats | Q34975588 | ||
| Insulin resistance: an adaptive mechanism becomes maladaptive in the current environment - an evolutionary perspective | Q38069296 | ||
| The Effect of High-Fat Diet-Induced Pathophysiological Changes in the Gut on Obesity: What Should be the Ideal Treatment? | Q38120639 | ||
| The use of adipose tissue-conditioned media to demonstrate the differential effects of fat depots on insulin-stimulated glucose uptake in a skeletal muscle cell line. | Q39614111 | ||
| Preadipocyte response and impairment of differentiation in an inflammatory environment | Q40154713 | ||
| Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice | Q40229345 | ||
| Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes | Q40266335 | ||
| Heterogeneity among white adipose tissue depots in male C57BL/6J mice | Q41139336 | ||
| Mediation of aldose reductase in lipopolysaccharide-induced inflammatory signals in mouse peritoneal macrophages | Q41886163 | ||
| Novel anti-inflammatory role of SLPI in adipose tissue and its regulation by high fat diet | Q41916397 | ||
| Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin/TCF4(TCF7L2)-dependent pathway. | Q42027895 | ||
| Basal lipolysis, not the degree of insulin resistance, differentiates large from small isolated adipocytes in high-fat fed mice. | Q42445781 | ||
| Regulation of lipolysis in small and large fat cells of the same subject | Q42495881 | ||
| Lipopolysaccharides reduce adipogenesis in 3T3-L1 adipocytes through activation of NF-κB pathway and downregulation of AMPK expression | Q42819277 | ||
| Insulin-sensitive obesity | Q43008676 | ||
| Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis | Q35081904 | ||
| How we detect microbes and respond to them: the Toll-like receptors and their transducers | Q35213803 | ||
| Effects of medium-chain triglycerides, long-chain triglycerides, or 2-monododecanoin on fatty acid composition in the portal vein, intestinal lymph, and systemic circulation in rats | Q35460682 | ||
| Beneficial effects of subcutaneous fat transplantation on metabolism | Q35485321 | ||
| Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease | Q35593129 | ||
| Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. | Q35693573 | ||
| Nutrient-induced inflammation in the intestine | Q35903426 | ||
| Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin-4. | Q36097975 | ||
| Counterpoint: visceral adiposity is not causally related to insulin resistance | Q36241138 | ||
| Ceramides in insulin resistance and lipotoxicity | Q36381594 | ||
| Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity | Q36431832 | ||
| Gut bacteria drive Kupffer cell expansion via MAMP-mediated ICAM-1 induction on sinusoidal endothelium and influence preservation-reperfusion injury after orthotopic liver transplantation | Q36495202 | ||
| Distinct developmental signatures of human abdominal and gluteal subcutaneous adipose tissue depots | Q36508832 | ||
| Postprandial metabolism of meal triglyceride in humans | Q36657551 | ||
| Depot-specific differences in adipocyte insulin sensitivity in mice are diet- and function-dependent. | Q36719133 | ||
| Debugging how bacteria manipulate the immune response. | Q36739044 | ||
| Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer? | Q36773597 | ||
| Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. | Q36826243 | ||
| Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs | Q36903421 | ||
| Induction of cytosolic phospholipase a2α is required for adipose neutrophil infiltration and hepatic insulin resistance early in the course of high-fat feeding. | Q37110575 | ||
| Cannabinoid type 1 receptor: another arrow in the adipocytes' bow. | Q37143610 | ||
| Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism | Q37173378 | ||
| Intestinal lipid absorption | Q37216738 | ||
| Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation | Q37236239 | ||
| Adipose tissue distribution is different in type 2 diabetes | Q37271535 | ||
| Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. | Q37376673 | ||
| Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells | Q37539899 | ||
| Fas (CD95) expression in myeloid cells promotes obesity‐induced muscle insulin resistance | Q37606420 | ||
| Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective | Q37670371 | ||
| Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk | Q37769024 | ||
| Obesity, visceral fat and Crohn's disease | Q37772038 | ||
| Review article: lymphatic system and associated adipose tissue in the development of inflammatory bowel disease | Q37773393 | ||
| Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease | Q38006586 | ||
| Visceral fat and metabolic inflammation: the portal theory revisited. | Q38056228 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metabolic syndrome | Q657193 |
| P304 | page(s) | 304-313 | |
| P577 | publication date | 2014-09-01 | |
| P1433 | published in | Physiology | Q1091804 |
| P1476 | title | The gut-adipose-liver axis in the metabolic syndrome | |
| P478 | volume | 29 |
| Q37228134 | 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Alters Lipid Metabolism and Depletes Immune Cell Populations in the Jejunum of C57BL/6 Mice |
| Q36812330 | A short bout of HFD promotes long-lasting hepatic lipid accumulation. |
| Q91522213 | ASK1 inhibits browning of white adipose tissue in obesity |
| Q88588840 | Age-related changes in the gut microbiota influence systemic inflammation and stroke outcome |
| Q39067441 | Alterations in the gut microbiota can elicit hypertension in rats |
| Q53653076 | Bardoxolone Methyl Prevents Mesenteric Fat Deposition and Inflammation in High-Fat Diet Mice. |
| Q96128387 | DR-region of Na+/K+-ATPase is a target to ameliorate hepatic insulin resistance in obese diabetic mice |
| Q40689856 | Effects of Dietary Different Doses of Copper and High Fructose Feeding on Rat Fecal Metabolome |
| Q97884390 | Emerging roles of Toll-like receptor 9 in cardiometabolic disorders |
| Q37497472 | Hypogonadism alters cecal and fecal microbiota in male mice |
| Q59335623 | Inflammatory Links Between High Fat Diets and Diseases |
| Q46286176 | Intrinsic aerobic capacity governs the associations between gut microbiota composition and fat metabolism age-dependently in rat siblings. |
| Q38245452 | Living a healthier lifestyle. |
| Q38692706 | Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome |
| Q37403502 | Mesenteric Lymphatic-Perilymphatic Adipose Crosstalk: Role in Alcohol-Induced Perilymphatic Adipose Tissue Inflammation |
| Q64235094 | Mesenteric adipose tissue B lymphocytes promote local and hepatic inflammation in non-alcoholic fatty liver disease mice |
| Q99591844 | Multi-omics profiling highlights lipid metabolism alterations in pigs fed low-dose antibiotics |
| Q36764022 | Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance |
| Q41547951 | Overexpression of C-type Natriuretic Peptide in Endothelial Cells Protects against Insulin Resistance and Inflammation during Diet-induced Obesity |
| Q64258818 | Profound Changes in Net Energy and Nitrogen Metabolites Fluxes within the Splanchnic Area during Overfeeding of Yucatan Mini Pigs That Remain Euglycemic |
| Q93348265 | Recent Advances in Body-on-a-Chip Systems |
| Q36764000 | Structure, function and metabolism of hepatic and adipose tissue lipid droplets: implications in alcoholic liver disease |
| Q51244848 | Xylobiose Prevents High-Fat Diet Induced Mice Obesity by Suppressing Mesenteric Fat Deposition and Metabolic Dysregulation. |
Search more.